[Hepatitis B: screening and treatment]

J P Mulkay1

  • 1Département d'Hépato-Gastroentérologie, C.H.U. Saint-Pierre, Bruxelles. jean-pierre_mulkay@stpierre-bru.be

Insights

Hepatitis B virus (HBV) infection is common and often asymptomatic, leading to underdiagnosis. Early screening, vaccination, and new antiviral treatments can prevent severe liver disease progression.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Context:

  • Hepatitis B virus (HBV) infection is a significant global health concern, surpassing HIV and HCV in prevalence.
  • Chronic hepatitis B (CHB) can lead to severe liver complications, including cirrhosis and hepatocellular carcinoma.
  • A large proportion of infected individuals remain unaware of their status due to asymptomatic presentation and insufficient screening.

Purpose:

  • To review current strategies for the prevention, diagnosis, and treatment of hepatitis B virus infection.
  • To highlight the importance of early detection and intervention in managing chronic hepatitis B.
  • To discuss the evolving landscape of antiviral therapies for CHB.

Summary:

  • HBV infection is highly prevalent, often asymptomatic, and preventable through vaccination.
  • Underdiagnosis is a major issue, necessitating improved screening protocols.
  • Recent advancements offer effective and tolerable antiviral treatments for CHB, improving patient outcomes.

Impact:

  • Emphasizes the critical need for enhanced HBV screening and vaccination programs.
  • Underscores the availability of effective treatments to halt liver disease progression.
  • Aims to improve patient management and reduce the burden of HBV-related liver disease.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...